A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

NCT01200394 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
256
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer